Related News for LUPIN

Lupin shares drop 0.99% as Sensex rises

update 25 Jan 03:07 PM

A total of 65,676 shares changed hands on the counter till 03:07PM (IST)

Trade Spotlight | What should you do with Sharda Cropchem, Bandhan Bank, Lupin, Cipla, Global Education?

update 25 Jan 07:41 AM

Here's what Malay Thakkar of GEPL Capital, suggests investors possessing these stocks when the market resumes trading today

Shares of Lupin rise as Nifty drops

update 24 Jan 10:10 AM

On the technical charts, the 200-day moving average of the stock stood at Rs 1027.38.

Lupin inks pact with Shenzhen Foncoo to introduce products in China

update 19 Jan 12:10 PM

The company would continue to explore additional partnership opportunities in China to leverage its global portfolio including complex generics and specialty medicines, Lupin President – Growth Markets, Fabrice Egros, said.

Lupin inks pact with Shenzhen Foncoo to introduce products in China

update 19 Jan 12:08 PM

This is the company’s first partnership arrangement in China and reinforces drug maker’s commitment to bringing high-quality generic and complex generic medicines to patients around the world, Lupin said in a statement.

Lupin stock price up 0.84 per cent as Sensex slides

update 18 Jan 11:37 AM

As of 31-Dec-2021, promoters held 46.53 per cent stake in the company, while FIIs held 15.28 per cent and domestic institutional investors had 13.26 per cent.

Lupin declines 1.4% as Sensex climbs

update 17 Jan 01:55 PM

The stock traded at a P/E multiple of -65.68, while the price-to-book value ratio stood at 3.36.

Lupin skids as failed USFDA specifications lead to recalls of 2 drugs

update 17 Jan 10:26 AM

The company’s scrip fell to a low of Rs 937.15 as against Rs 951.80 at previous close on the National Stock Exchange.

Lupin is a contrarian bet for this year: Sandip Sabharwal

update 14 Jan 10:41 AM

"Don't see any big upsides coming into Reliance, at least this year."

Buy Lupin, target price Rs 1150: Emkay Global

update 12 Jan 11:30 AM

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42717.22 Crore) operating in Pharmaceuticals sector.